A consultant paediatrician was barred from all clinical practice by his own hospital trust in March 2023, five months before the trial that relied on his testimony reached its verdict. The restriction, imposed by University College London hospitals trust, never reached the jury, the judge, or the defence team at Manchester crown court.
Prof Peter Hindmarsh, a consultant paediatric endocrinologist at UCLH since 1991 and a professor at UCL, was central to the prosecution’s case that Lucy Letby, a neonatal nurse at the Countess of Chester hospital, had injected insulin into intravenous fluid bags. Lead prosecutor Nick Johnson KC introduced him to jurors as “the pre-eminent expert” on insulin. Yet the clinical oversight machinery at his own trust had already concluded his practice could not safely continue.
Documents seen by the Guardian show the sequence in detail. On 15 March 2023, UCLH informed the General Medical Council that it had excluded Hindmarsh from treating patients at all. That came less than three weeks after his second and final day of evidence on 24 February. A UCLH medical director, Dr Tim Hodgson, told the regulator that Hindmarsh had breached a supervision order and had given independent medical advice on three child patients, two involving insulin and diabetes. In two of those cases he advised families to stop giving children insulin at home; one child then suffered diabetic ketoacidosis, a life-threatening complication caused by a severe lack of insulin.
Hodgson wrote that UCLH was “not presently in a position to allow Professor [Hindmarsh] to practice clinically even under supervision”, adding that the trust could not “accept the level of risk Professor Hindmarsh appears to pose to children and young people”. Colleagues had raised written concerns that he over-focused on rare causes of hypoglycaemia and diabetes while failing to address more common ones, and that in one case he was “not treating high glucose levels appropriately”.
The restrictions stretch back further. The GMC opened its investigation on 25 November 2022, the same day Hindmarsh first gave evidence for the prosecution, after Great Ormond Street hospital reported “multiple and wide-ranging concerns”, including alleged harm to patients. UCLH, running its own formal investigation, reported similar concerns in December 2022. In January 2023 a tribunal ordered that he could work only at UCLH and only under supervision, because otherwise he “may pose a real risk to members of the public”.
When the March 2023 exclusion prompted the GMC to apply for suspension, a three-person medical practitioners tribunal declined in April 2023, ruling suspension disproportionate. It tightened the supervision requirement instead, explicitly allowing him to continue as an expert witness. The order had little practical effect. UCLH had already barred him from clinical practice altogether.
The disclosure chain, however, stopped well short of the courtroom. Hindmarsh told Cheshire constabulary in December 2022 that he was under GMC investigation, and the Crown Prosecution Service passed that to Letby’s barrister, Ben Myers KC, in February 2023, noting it would oppose the jury being told because no final adjudication had been reached. But neither the police nor the CPS appears to have been told about the trust’s exclusion or the April tribunal ruling; the CPS says it disclosed everything it knew. Had the defence been informed, it could have challenged Hindmarsh’s credibility and applied for his evidence to be dismissed. Failures of disclosure are recognised grounds for referral to the Criminal Cases Review Commission.
In November 2024 Hindmarsh applied to remove himself from the medical register, and the GMC allowed it, ending the investigation with no final determination. Letby’s lawyer, Mark McDonald, has applied to the CCRC, backed by reports from seven experts who say Hindmarsh’s calculations were factually inaccurate and that immunoassay blood tests, presented at trial as definitive, are known to be fallible. Hindmarsh declined to answer the Guardian’s questions, with a representative saying he “has no comment in relation to these questions and points”.
Whether the CCRC treats the broken disclosure chain as sufficient grounds to revisit the conviction now rests with the commission.